Items where authors include "Hall, P"

Article

Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029

Pearce, J, Swinson, D, Cairns, D orcid.org/0000-0002-2338-0179 et al. (7 more authors) (2022) Frailty and treatment outcome in advanced gastro-oesophageal cancer: An exploratory analysis of the GO2 trial. Journal of Geriatric Oncology, 13 (3). pp. 265-390. ISSN 1879-4068

Dennis, J, Tyrer, JP, Walker, LC et al. (121 more authors) (2022) Rare germline copy number variants (CNVs) and breast cancer risk. Communications Biology, 5. 65. ISSN 2399-3642

Ahearn, TU, Zhang, H, Michailidou, K et al. (202 more authors) (2022) Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Research, 24 (1). 2.

Spencer, K orcid.org/0000-0002-6846-4341, Defourny, N, Tunstall, D et al. (5 more authors) (2022) Variable and fixed costs in NHS radiotherapy; consequences for increasing hypo fractionation. Radiotherapy and Oncology, 166. pp. 180-188. ISSN 0167-8140

Park, HA, Neumeyer, S, Michailidou, K et al. (274 more authors) (2021) Mendelian randomisation study of smoking exposure in relation to breast cancer risk. British Journal of Cancer, 125. pp. 1135-1145. ISSN 0007-0920

Downing, A orcid.org/0000-0002-0335-7801, Hall, P, Birch, R orcid.org/0000-0003-1579-1397 et al. (6 more authors) (2021) Data Resource Profile: The COloRECTal cancer data repository (CORECT-R). International Journal of Epidemiology, 50 (5). 1418-1418k. ISSN 0300-5771

Diernberger, K, Shinkins, B orcid.org/0000-0001-5350-1018, Hall, P et al. (2 more authors) (2021) Incompatible: end-of-life care and health economics. BMJ Supportive and Palliative Care, 11. pp. 296-298. ISSN 2045-4368

Ruth, KS, Day, FR, Hussain, J et al. (265 more authors) (2021) Genetic insights into biological mechanisms governing human ovarian ageing. Nature, 596 (7872). pp. 393-397. ISSN 0028-0836

Morra, A, Escala-Garcia, M, Beesley, J et al. (175 more authors) (2021) Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research, 23 (1). 86.

Baxter, JS, Johnson, N, Tomczyk, K et al. (180 more authors) (2021) Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. The American Journal of Human Genetics, 108 (7). pp. 1190-1203. ISSN 0002-9297

Park, JY, Choi, JY, Choi, J et al. (90 more authors) (2021) Gene-environment interactions relevant to estrogen and risk of breast cancer: Can gene-environment interactions be detected only among candidate snps from genome-wide association studies? Cancers, 13 (10). 2370. ISSN 2072-6694

Johnson, N, Maguire, S, Morra, A et al. (145 more authors) (2021) CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer, 124 (4). pp. 842-854. ISSN 0007-0920

Luta, X, Diernberger, K, Bowden, J et al. (6 more authors) (2020) Healthcare trajectories and costs in the last year of life: a retrospective primary care and hospital analysis. BMJ Supportive and Palliative Care. ISSN 2045-435X

Kramer, I, Hooning, MJ, Mavaddat, N et al. (264 more authors) (2020) Breast cancer polygenic risk score and contralateral breast cancer risk. The American Journal of Human Genetics, 107 (5). pp. 837-848. ISSN 0002-9297

Zhang, YD, Hurson, AN, Zhang, H et al. (102 more authors) (2020) Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nature Communications, 11. 3353.

Franks, KN, McParland, L, Webster, J et al. (21 more authors) (2020) SABRTOOTH: A randomised controlled feasibility study of Stereotactic Ablative Radiotherapy (SABR) with surgery in paTients with peripheral stage I nOn-small cell lung cancer (NSCLC) cOnsidered To be at Higher risk of complications from surgical resection. European Respiratory Journal. ISSN 0903-1936

Feng, H, Gusev, A, Pasaniuc, B et al. (249 more authors) (2020) Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status. Genetic Epidemiology, 44 (5). pp. 442-468. ISSN 0741-0395

Zhang, H, Ahearn, TU, Lecarpentier, J et al. (269 more authors) (2020) Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nature Genetics, 52 (6). pp. 572-581. ISSN 1061-4036

Kapoor, PM, Lindström, S, Behrens, S et al. (147 more authors) (2020) Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium. International Journal of Epidemiology, 49 (1). pp. 216-232. ISSN 0300-5771

Escala-Garcia, M, Abraham, J, Andrulis, IL et al. (142 more authors) (2020) A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. Nature Communications, 11 (1). 312.

Fachal, L, Aschard, H, Beesley, J et al. (338 more authors) (2020) Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics, 52 (1). pp. 56-73. ISSN 1061-4036

Spencer, K orcid.org/0000-0002-6846-4341, Velikova, G orcid.org/0000-0003-1899-5942, Henry, A orcid.org/0000-0002-5379-6618 et al. (3 more authors) (2019) Net Pain Relief After Palliative Radiation Therapy for Painful Bone Metastases: A Useful Measure to Reflect Response Duration? A Further Analysis of the Dutch Bone Metastasis Study. International Journal of Radiation Oncology*Biology*Physics, 105 (3). pp. 559-566. ISSN 0360-3016

Abel, L, Shinkins, B orcid.org/0000-0001-5350-1018, Smith, A orcid.org/0000-0001-7709-1869 et al. (8 more authors) (2019) Early Economic Evaluation of Diagnostic Technologies: Experiences of the NIHR Diagnostic Evidence Co-operatives. Medical Decision Making, 39 (7). pp. 857-866. ISSN 0272-989X

MacLullich, AMJ, Shenkin, SD, Goodacre, S et al. (18 more authors) (2019) The 4 'A's test for detecting delirium in acute medical patients: a diagnostic accuracy study. Health Technology Assessment, 23 (40). pp. 1-194. ISSN 1366-5278

Shu, X, Wu, L, Khankari, NK et al. (203 more authors) (2019) Associations of obesity and circulating insulin and glucose with breast cancer risk : a Mendelian randomization analysis. International Journal of Epidemiology, 48 (3). pp. 795-806. ISSN 0300-5771

Jiang, X, Finucane, HK orcid.org/0000-0003-3864-9828, Schumacher, FR orcid.org/0000-0002-3073-7463 et al. (330 more authors) (2019) Shared heritability and functional enrichment across six solid cancers. Nature Communications, 10. 431. ISSN 2041-1723

Mavaddat, N, Michailidou, K, Dennis, J et al. (266 more authors) (2019) Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. The American Journal of Human Genetics, 104 (1). pp. 21-34. ISSN 0002-9297

Smith, AF orcid.org/0000-0001-7709-1869, Messenger, M orcid.org/0000-0002-4975-0158, Hall, P et al. (1 more author) (2018) The Role of Measurement Uncertainty in Health Technology Assessments (HTAs) of In Vitro Tests. PharmacoEconomics, 36 (7). pp. 823-835. ISSN 1170-7690

Jepson, M, Elliott, D, Conefrey, C et al. (104 more authors) (2018) An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment. Journal of Clinical Epidemiology, 99. pp. 75-83. ISSN 0895-4356

Gopalakrishna, G, Langendam, M, Scholten, R et al. (470 more authors) (2017) Erratum to: Methods for evaluating medical tests and biomarkers. Diagnostic and Prognostic Research, 1 (11). pp. 2-5.

Bell, R, Brown, JM orcid.org/0000-0002-2719-7064, Parmar, M et al. (18 more authors) (2017) Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer. Annals of Oncology, 28 (4). pp. 754-760. ISSN 0923-7534

Gopalakrishna, G, Langendam, M, Scholten, R et al. (468 more authors) (2017) Erratum to: Methods for evaluating medical tests and biomarkers. Diagnostic and Prognostic Research, 1. 11. ISSN 2397-7523

Liu, J, Lončar, I, Collée, JM et al. (97 more authors) (2016) rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk. Scientific Reports, 6. p. 36874. ISSN 2045-2322

Marti, J, Hall, P, Hamilton, P et al. (6 more authors) (2016) One-year resource utilisation, costs and quality of life in patients with acute respiratory distress syndrome (ARDS): Secondary analysis of a randomised controlled trial. Journal of Intensive Care (4). 56.

Mehanna, H, Wong, W-L, McConkey, CC et al. (15 more authors) (2016) PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer. New England Journal of Medicine, 374 (15). pp. 1444-1454. ISSN 0028-4793

Day, FR, Ruth, KS, Thompson, DJ et al. (240 more authors) (2015) Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nature Genetics, 47 (11). ISSN 1061-4036

Darabi, H, McCue, K, Beesley, J et al. (126 more authors) (2015) Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. American Journal of Human Genetics .

Hall, P, Smith, AFC, Vargas-Palacios, A et al. (20 more authors) (2015) UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer. Cancer Research, 75 (9). Abstract P6-08-11. ISSN 0008-5472

Meads, DM, Hulme, CT, Hall, P et al. (1 more author) (2014) The cost-effectiveness of primary care referral to a UK commercial weight loss programme. Clinical obesity, 4 (6). 324 - 332. ISSN 1758-8103

Perry, JRB, Day, F, Elks, CE et al. (200 more authors) (2014) Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature, 514 (7520). 92-+. ISSN 0028-0836

Ghoussaini, M, Edwards, SL, Michailidou, K et al. (209 more authors) (2014) Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature Communications, 5. 4999. ISSN 2041-1723

Longo, R orcid.org/0000-0002-9379-1627, Baxter, P orcid.org/0000-0003-2699-3103, Hall, P et al. (4 more authors) (2014) Methods for identifying the cost-effective case definition cut-off for sequential monitoring tests: An extension of phelps and mushlin. PharmacoEconomics, 32 (4). pp. 327-334. ISSN 1170-7690

Garcia-Closas, M, Couch, FJ, Lindstrom, S et al. (271 more authors) (2013) Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature Genetics, 45 (4). pp. 392-398. ISSN 1061-4036

Bojesen, SE, Pooley, KA, Johnatty, SE et al. (442 more authors) (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics, 45 (4). pp. 371-384. ISSN 1061-4036

Ghoussaini, M, Fletcher, O, Michailidou, K et al. (184 more authors) (2012) Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nature Genetics, 44 (3). pp. 312-318. ISSN 1061-4036

Book Section

Messenger, M orcid.org/0000-0002-4975-0158, Hall, P, Shinkins, B et al. (3 more authors) (2017) Developing Diagnostic Tests for Precision Oncology. In: Copson, ER, Hall, P, Board, RE, Cook, G and Selby, P, (eds.) Problem Solving Through Precision Oncology A Case Study Based Reference and Learning Resource. Clinical Publishing , Abingdon, Oxon, UK , pp. 67-75. ISBN 978-1-84692-111-7

Monograph

Mehanna, H, McConkey, CC, Rahman, JK et al. (12 more authors) (2017) PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer. Report. NIHR Journals Library , Health Technology Assessment, Volume 21, Issue 17. ISSN 1366-5278

Conference or Workshop Item

Hall, P, Swinson, D, Lord, S et al. (23 more authors) (2019) Optimizing Chemotherapy for Frail and Elderly Patients with Advanced Gastroesophageal Cancer (aGOAC): the GO2 Phase III Trial. In: 2019 NCRI Cancer Conference of National Cancer Research Institute, 03-05 Nov 2019, Glasgow, Scotland, UK.

Hall, P, Swinson, D, Lord, S et al. (7 more authors) (2019) Chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): Quality of Life (QoL) results from the GO2 phase III trial. In: 44th ESMO Congress (ESMO 2019), 27 Sep - 01 Oct 2019, Barcelona, Spain.

Schmid, P, Abraham, J, Chan, S et al. (17 more authors) (2018) AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial. In: 2018 ASCO Annual Meeting, 01-05 Jun 2018, Chicago, IL, USA.

Proceedings Paper

Spencer, K, Bojke, C, Henry, A et al. (5 more authors) (2020) OC-0079: Can SABR for painful bone metastases ever be cost-effective in the NHS? In: Radiotherapy and Oncology. ESTRO 2020, 28 Nov - 01 Dec 2020, Online. , S36-S37.

Spencer, K, Hall, P, Henry, A orcid.org/0000-0002-5379-6618 et al. (6 more authors) (2020) PH-0522: Fractionation and early mortality in palliative radiotherapy across the English NHS. In: Radiotherapy and Oncology. ESTRO 2020, 28 Nov - 01 Dec 2020, Online. Elsevier , S285-S286.

Hulme, C, Hall, P, Shinkins, B orcid.org/0000-0001-5350-1018 et al. (5 more authors) (2018) PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Cost effectiveness analysis results. In: Annals of Oncology. ESMO 2018, 19-23 Oct 2018, Munich, Germany. Oxford University Press .

Spencer, K orcid.org/0000-0002-6846-4341, Van den Hout, W, Henry, A orcid.org/0000-0002-5379-6618 et al. (5 more authors) (2018) PO-0847: Pain response and quality of life with survival post palliative radiotherapy for bone metastases. In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S442-S443.

Gopalakrishna, G, Langendam, M, Scholten, R et al. (468 more authors) (2017) Methods for Evaluating Medical Tests and Biomarkers. In: Diagnostic and Prognostic Research. Methods for evaluating medical tests and biomarkers: Symposium 2016, 19-20 Jul 2016, Birmingham, UK. BMC .